Hill Stephen J.
Lyell Immunopharma, Inc. · Chief Operating Officer
Hill Stephen J. is listed in filings as Chief Operating Officer at Lyell Immunopharma, Inc.. This profile follows SEC Form 4 activity through Feb 12, 2026, including sale activity. Recent filings connect the profile to Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Feb 26, 2025 to Feb 12, 2026. Reported amounts are shown as $28.9K to $2.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $29k1.2k shares | SellFeb 11, 2026 | $23.39 | $12.92 |